Rab10 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
[^1]
| Attribute | Value |
|-----------|-------|
| Gene Symbol | RAB10 |
| Full Name | RAB10, Member RAS Oncogene Family |
| Chromosomal Location | 2p22.3 |
| NCBI Gene ID | 10890 |
| Ensembl ID | ENSG00000100705 |
| UniProt ID | Q9Y2P8 |
| OMIM ID | - |
| Gene Family | Rab GTPase family |
}
RAB10 encodes a member of the Rab GTPase family involved in intracellular membrane trafficking. It plays critical roles in exocytic and endocytic pathways, including polarized membrane trafficking, autophagy, and lipid transport. RAB10 is essential for neuronal function, synaptic vesicle trafficking, dendrite morphogenesis, and myelin sheath formation.
The Rab GTPase family comprises over 60 members in humans, functioning as molecular switches that control vesicle transport between cellular compartments. RAB10 is particularly important for polarized trafficking in epithelial cells and neurons, where it directs cargo to specific subcellular domains. Its functions in autophagy and lipid metabolism make it relevant to several neurodegenerative diseases.
- Chromosome: 2
- Location: 2p22.3
- Exons: Multiple protein-coding exons spanning approximately 15 kb
- Transcript: Approximately 2.5 kb mRNA
- Promoter: Contains regulatory elements for ubiquitous expression
- Multiple transcript variants identified
- Some variants show tissue-specific expression patterns
RAB10 protein has the characteristic Rab GTPase fold:
- GTP-binding domain: Five conserved G motifs for nucleotide binding
- Switch I region: Conformational change upon GTP/GDP exchange
- Switch II region: Effector protein interaction site
- Hypervariable C-terminal region: Determines subcellular targeting
- C XC motif: Prenylation for membrane association
RAB10 regulates multiple trafficking pathways:
- Exocytosis: Directs vesicles from the trans-Golgi network to the plasma membrane
- Endocytic recycling: Controls recycling endosome trafficking
- Polarized trafficking: Targets cargo to specific membrane domains
- Autophagy: Regulates autophagosome formation and maturation
RAB10 localizes to:
- Trans-Golgi network: Major site of RAB10 function
- Recycling endosomes: Endocytic recycling compartment
- Plasma membrane: Especially in polarized cells
- Autophagosomes: During autophagy
RAB10 interacts with key effectors:
| Effector |
Function |
| EH domain proteins |
NASP, RABEP1 - cargo recognition |
| Myosin-Va/Vb |
Motor-driven transport |
| Exocyst complex |
Plasma membrane targeting |
| Autophagy proteins |
LC3, ATG14 |
RAB10 is ubiquitously expressed with highest levels in:
- Brain (cerebral cortex, hippocampus)
- Testis
- Kidney
- Liver
- Adipose tissue
RAB10 contributes to AD pathogenesis:
- APP trafficking: RAB10 regulates amyloid precursor protein processing
- Synaptic function: Altered RAB10 in AD brains affects synaptic vesicle dynamics
- Tau secretion: RAB10 participates in pathological tau spread between neurons
- Lipid metabolism: RAB10 in lipid droplet trafficking may be disrupted in AD
RAB10 is implicated in PD:
- Mitophagy: RAB10 participates in PINK1/Parkin-mediated mitophagy
- α-Syn secretion: RAB10 may regulate intercellular spread of α-synuclein
- Lysosomal function: RAB10 in endolysosomal trafficking
- Evidence: RAB10 genetic variants associated with PD risk
In ALS:
- Axonal transport: RAB10 in vesicle trafficking along axons
- Motor neuron function: Critical for neuromuscular junction maintenance
- Autophagy: RAB10 dysfunction impairs protein quality control
RAB10 plays roles in:
- Myelin maintenance: Essential for oligodendrocyte function
- Demyelination: May affect myelin repair processes
- Therapeutic potential: Targeting RAB10 for remyelination
| Approach |
Target |
Status |
| GEF modulators |
Enhance RAB10 function |
Preclinical |
| GAP inhibitors |
Increase RAB10-GTP |
Research |
| Effector blockers |
Disrupt pathological interactions |
Research |
- Viral delivery: AAV-mediated RAB10 expression modulation
- CRISPR: Target RAB10 for upregulation or downregulation
- RNAi: Knockdown of pathological RAB10 variants
- CSF RAB10: Potential marker of neuronal integrity
- Blood RAB10: Peripheral biomarker for CNS diseases
- Expression studies: Correlate with disease progression
- Structural studies: Cryo-EM of RAB10-effector complexes
- Live cell imaging: Visualize RAB10 dynamics
- Proteomics: Identify novel RAB10 interactors
- Single-cell studies: Cell-type-specific functions
- Genetic association studies: RAB10 variants in neurodegeneration
- Biomarker validation: CSF and blood RAB10 as biomarkers
- Therapeutic trials: RAB10-targeting compounds
| Model |
Application |
| Knockout mice |
Baseline RAB10 function |
| Conditional knockouts |
Tissue-specific roles |
| Transgenic overexpression |
Disease models |
| Zebra fish |
Developmental studies |
- Knockout mice: Viable with mild metabolic phenotypes
- Conditional models: Reveal tissue-specific functions
The study of Rab10 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.